Literature DB >> 18792916

Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress.

Arianna Calistri1, Claudia Del Vecchio, Cristiano Salata, Michele Celestino, Marta Celegato, Heinrich Göttlinger, Giorgio Palù, Cristina Parolin.   

Abstract

RNA-enveloped viruses bud from infected cells by exploiting the multivesicular body (MVB) pathway. In this context, ubiquitination of structural viral proteins and their direct interaction with cellular factors involved in the MVB biogenesis through short proline rich regions, named late domains (L-domains), are crucial mechanisms. Here we report that, in contrast with the human immunodeficiency virus (HIV), the feline immunodeficiency virus (FIV), a non-primate lentivirus, is strictly dependent for its budding on a "PSAP"-type L-domain, mapping in the carboxy-terminal region of Gag, irrespective of a functional viral protease. Moreover, we provide evidence that FIV egress is related to Gag ubiquitination, that is, linked to the presence of an active L-domain. Finally, although FIV Gag does not contain a PPxY motif, we show that the Nedd4-2s ubiquitin ligase enhances FIV Gag ubiquitination and it is capable to rescue viral mutants lacking a functional L-domain. In conclusion, our data bring to light peculiar aspects of FIV egress, but we also demonstrate that a non-primate lentivirus shares with HIV-1 a novel mechanism of connection to the cellular budding machinery. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18792916      PMCID: PMC2593634          DOI: 10.1002/jcp.21587

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  38 in total

1.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Generation of lentivirus vectors using recombinant baculoviruses.

Authors:  H P Lesch; S Turpeinen; E A Niskanen; A J Mähönen; K J Airenne; S Ylä-Herttuala
Journal:  Gene Ther       Date:  2008-05-08       Impact factor: 5.250

3.  Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1.

Authors:  J H Elder; G A Dean; E A Hoover; J A Hoxie; M H Malim; L Mathes; J C Neil; T W North; E Sparger; M B Tompkins; W A Tompkins; J Yamamoto; N Yuhki; N C Pedersen; R H Miller
Journal:  AIDS Res Hum Retroviruses       Date:  1998-06-10       Impact factor: 2.205

4.  Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect.

Authors:  Eva Gottwein; Stefanie Jäger; Anja Habermann; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

5.  Late assembly domain function can exhibit context dependence and involves ubiquitin residues implicated in endocytosis.

Authors:  Bettina Strack; Arianna Calistri; Heinrich G Göttlinger
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

Review 6.  Lessons from the cat: development of vaccines against lentiviruses.

Authors:  Stephen P Dunham
Journal:  Vet Immunol Immunopathol       Date:  2006-05-05       Impact factor: 2.046

Review 7.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Functional domains in the feline immunodeficiency virus nucleocapsid protein.

Authors:  Mariana L Manrique; María L Rauddi; Silvia A González; José L Affranchino
Journal:  Virology       Date:  2004-09-15       Impact factor: 3.616

Review 9.  FIV: from lentivirus to lentivector.

Authors:  Dyana T Saenz; Eric M Poeschla
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

10.  Streamlined design of a self-inactivating feline immunodeficiency virus vector for transducing ex vivo dendritic cells and T lymphocytes.

Authors:  Mauro Pistello; Laura Vannucci; Alessia Ravani; Francesca Bonci; Flavia Chiuppesi; Barbara del Santo; Giulia Freer; Mauro Bendinelli
Journal:  Genet Vaccines Ther       Date:  2007-09-19
View more
  24 in total

1.  Recruitment of the ESCRT machinery to a putative seven-transmembrane-domain receptor is mediated by an arrestin-related protein.

Authors:  Antonio Herrador; Silvia Herranz; David Lara; Olivier Vincent
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

2.  The role of ITCH protein in human T-cell leukemia virus type 1 release.

Authors:  Batsukh Dorjbal; David Derse; Patricia Lloyd; Ferri Soheilian; Kunio Nagashima; Gisela Heidecker
Journal:  J Biol Chem       Date:  2011-07-01       Impact factor: 5.157

3.  ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding.

Authors:  Ziying Han; Cari A Sagum; Mark T Bedford; Sachdev S Sidhu; Marius Sudol; Ronald N Harty
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

4.  A leucine residue in the C terminus of human parainfluenza virus type 3 matrix protein is essential for efficient virus-like particle and virion release.

Authors:  Guangyuan Zhang; Shengwei Zhang; Binbin Ding; Xiaodan Yang; Longyun Chen; Qin Yan; Yanliang Jiang; Yi Zhong; Mingzhou Chen
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

Review 5.  How ubiquitin functions with ESCRTs.

Authors:  S Brookhart Shields; Robert C Piper
Journal:  Traffic       Date:  2011-07-27       Impact factor: 6.215

6.  Late domain-independent rescue of a release-deficient Moloney murine leukemia virus by the ubiquitin ligase itch.

Authors:  Joshua A Jadwin; Victoria Rudd; Paola Sette; Swathi Challa; Fadila Bouamr
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

7.  Mutations in the feline immunodeficiency virus envelope glycoprotein confer resistance to a dominant-negative fragment of Tsg101 by enhancing infectivity and cell-to-cell virus transmission.

Authors:  Benjamin G Luttge; Prashant Panchal; Vinita Puri; Mary Ann Checkley; Eric O Freed
Journal:  Biochim Biophys Acta       Date:  2013-09-10

Review 8.  Virus budding and the ESCRT pathway.

Authors:  Jörg Votteler; Wesley I Sundquist
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

Review 9.  FIV Gag: virus assembly and host-cell interactions.

Authors:  Benjamin G Luttge; Eric O Freed
Journal:  Vet Immunol Immunopathol       Date:  2009-10-14       Impact factor: 2.046

Review 10.  Antiviral activity of innate immune protein ISG15.

Authors:  Ronald N Harty; Paula M Pitha; Atsushi Okumura
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.